NEXPOINT ASSET MANAGEMENT, L.P. - EYEPOINT PHARMACEUTICALS INC ownership

EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G100. A total of 1 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NEXPOINT ASSET MANAGEMENT, L.P. ownership history of EYEPOINT PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$18,000
-76.3%
33,933
-66.1%
0.00%
-76.5%
Q2 2020$76,000
-53.1%
100,000
-36.9%
0.02%
-45.2%
Q1 2020$162,000
-80.8%
158,520
-70.9%
0.03%
-51.6%
Q4 2019$845,000
-14.3%
545,0000.0%0.06%
+4.9%
Q3 2019$986,000545,0000.06%
Other shareholders
EYEPOINT PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 41,909,219$21,793,00011.58%
Kore Private Wealth LLC 202,366$105,0000.02%
BARD ASSOCIATES INC 335,750$175,0000.02%
HighTower Advisors, LLC 5,284,688$2,738,0000.01%
GSA CAPITAL PARTNERS LLP 126,529$66,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 654,200$339,0000.01%
Virtu Financial LLC 57,076$30,0000.01%
WEDBUSH SECURITIES INC 81,500$42,0000.00%
NEXPOINT ASSET MANAGEMENT, L.P. 33,933$18,0000.00%
MATRIX ASSET ADVISORS INC/NY 39,500$20,0000.00%
View complete list of EYEPOINT PHARMACEUTICALS INC shareholders